Barbieri, M.A.; Russo, G.; Cicala, G.; Zito, C.; Spina, E.; Silvestris, N.; Santarpia, M.
Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014–2023). Cancers 2025, 17, 1755.
https://doi.org/10.3390/cancers17111755
AMA Style
Barbieri MA, Russo G, Cicala G, Zito C, Spina E, Silvestris N, Santarpia M.
Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014–2023). Cancers. 2025; 17(11):1755.
https://doi.org/10.3390/cancers17111755
Chicago/Turabian Style
Barbieri, Maria Antonietta, Giulia Russo, Giuseppe Cicala, Concetta Zito, Edoardo Spina, Nicola Silvestris, and Mariacarmela Santarpia.
2025. "Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014–2023)" Cancers 17, no. 11: 1755.
https://doi.org/10.3390/cancers17111755
APA Style
Barbieri, M. A., Russo, G., Cicala, G., Zito, C., Spina, E., Silvestris, N., & Santarpia, M.
(2025). Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014–2023). Cancers, 17(11), 1755.
https://doi.org/10.3390/cancers17111755
